Refine by
Surgical Stabilization Products Articles & Analysis: Older
40 news found
Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund. This funding will support Synaptive Medical’s $2.8 million project to expand manufacturing and research and development activities related to the company’s head-only Magnetic Resonance Imaging (MRI) system. The Synaptive MRI is a 0.5T system that was designed to overcome ...
(FREMONT, CA) November 14, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced the implementation of a new, experienced commercial leadership team. Following a recent successful financing round which will enable accelerated commercialization of several new products, THINK Surgical is excited to introduce the leadership team who will lead ...
(FREMONT, CA) October 26, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots today announced that KDB Investment Global Healthcare of Korea, a new investor, has invested $100M in the company to enable a faster commercial launch of several new products. This investment will allow THINK Surgical to bring new products to market which will offer a common ...
McKinsey’s Values and Value event series convenes ESG leaders from across the Life Sciences industry to discuss the hot topics, questions, wins, and challenges that arise on the path to improving the industry’s environmental and social impact. During the session, Rob Chase, Founder and President of NewGen Surgical, and Samantha Smith, Director at Medtronic’s Sustainability ...
NewGen Surgical Inc. announced today that it has earned the U.S. Department of Agriculture (USDA) Certified Biobased Product label on all product lines. Managed by the U.S. Department of Agriculture (USDA), the BioPreferred Program is an initiative created by the 2002 Farm Bill (and recently reauthorized by the 2018 Farm Bill), to increase the development, purchase, and use of biobased products. ...
Caldera Medical, a medical device company that develops best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, and Polyps announced the launch of Desara® TVez, an expansion to their Desara® Family of products. “Staying true to our commitment of being surgeon and patient focused, Caldera Medical collaborated with dozens of leading ...
The Middle East’s largest medical exhibition has proven its value for Scottish SME Clear Surgical Ltd – who have landed a string of new business opportunities following their first-ever exhibition at the event, and are now in advance discussion to strike a 7-figure deal. The future looks bright for Clear Surgical Ltd following their exhibition at Arab Health 2020 as part of the ABHI ...
Acumed, a Colson Medical - Marmon - Berkshire Hathaway company, is excited to announce the acquisition of ExsoMed, a provider of innovative solutions for hand surgery. The addition of ExsoMed, whose products support an intramedullary approach to treating hand fractures, enhances Acumed’s comprehensive portfolio of upper extremity solutions for simple to complex injuries. Acumed, a Colson ...
Surgical has signed the Department of Health and Human Services (HHS) climate pledge initiative NewGen in partnership with the White House to mobilize the healthcare sector to reduce carbon emissions. On April 22, 2022, the HHS issued a call to action for healthcare stakeholders to commit to tackling the climate crisis through a new initiative aimed at reducing emissions across the healthcare ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation wound care products and its JV partner Diversa S.A. have announced a new distribution agreement with Grupo Suprimed to market and sell the dermaPACE® System in the private healthcare market in Brazil. The dermaPACE® System is currently licensed or approved for advanced wound care indications in Brazil, Mexico and ...
Flowonix Medical and Miratech Medical today announced the acquisition of the U.S. distribution rights to Flowonix’s state-of-the-art targeted drug delivery system for the treatment of chronic pain and spasticity by Miratech Medical in a transaction that closed on May 11th. Miratech has long served as the exclusive agent for Flowonix products for certain markets, primarily in the Midwest. ...
Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and cell-based therapies, announced today that it has acquired TheraCell, Inc., a California-based regenerative medicine company. The acquisition will strengthen Isto’s focus on offering extraordinary solutions for surgical and clinical care procedures within spine, orthopedics, and sports medicine. ...
CMR Surgical & Surgical Innovations develop new surgical hybrid port access system Surgical Innovations’ new YelloPort Elite™ 5mm, with reusable trocar and canula, reduces cost and waste generated when compared with traditional fully single use Port Access Systems Developed with CMR Surgical, the port access system is the latest addition to Surgical Innovation’s ...
London, UK and Boston, MA – March 22, 2022 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced that its venture capital arm, Hikma Ventures has led an $15 million USD round of financing for Activ Surgical, a pioneering digital surgery imaging startup that is developing groundbreaking interoperative surgical intelligence hardware and software. ...
Coralville, Iowa and Deerfield, Ill., March 9, 2022 – Digital Diagnostics and Baxter International Inc. announced a long-term strategic partnership to help front line care providers deliver high-quality care and improve care outcomes. The partnership includes plans to offer Digital Diagnostics’ industry-leading IDx-DR® autonomous AI software as a diagnostic service combined with ...
Gières (Grenoble), France, December, 14 2021 The funds will enable eCential Robotics to invest in research and development to offer a fully unified and comprehensive robotic solution for less invasive surgical procedures, assisting surgeons from planning through to execution. The operation comes under secured global financing of close to €100 million in equity, quasi-equity ...
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today announced that Maria Palasis, Ph.D., Lyra's President and Chief Executive Officer, will present in a virtual format at three ...
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues will host a virtual event with leading chronic rhinosinusitis (CRS) experts to highlight the Company's LYR-210 and LYR-220 clinical ...
MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces that C. Lowry Barnes, MD, Chair of Orthopaedics at the University of Arkansas for Medical Sciences Health, has officially joined the company’s leadership team as Medical Director. Dr. Barnes is a board-certified, fellowship-trained total joint surgeon with a special interest in hip and knee ...
LYR-210 pharmacokinetics indicate a constant and steady daily dose of Mometasone Furoate is delivered to patients LANTERN study manuscript wins ARS Annual Meeting 2021 Clinical Science Maurice Cottle Award Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of ...